SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve 1. To Approve Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter ended 30th June 2024. 2. To Consider and appoint Shri. Vijay Kottapalli (DIN: 10245156) as Additional Director (Non Executive Independent Director) of the Company. 3. To consider/recommend Dividend for the Financial Year 2023-24.